Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (108)
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
3,839
Price
$16.71
Total Value
$64.15K
Shares Held After
134,588
% of Holdings
2.8%
Sionna Therapeutics, Inc. (SION)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
33,800
Price
$7.46
Total Value
$252.15K
Shares Held After
3,448,812
% of Holdings
1.0%
Sionna Therapeutics, Inc. (SION)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
3,415,011
Price
$6.32
Total Value
$21.58M
Shares Held After
3,482,612
% of Holdings
49.5%
CRISPR Therapeutics AG (CRSP)
Behbahani Ali — Director
Shares
13,679
Price
$57.09
Total Value
$780.94K
Shares Held After
16,637
% of Holdings
45.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
1,279
Price
$69.57
Total Value
$88.98K
Shares Held After
495,686
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,721
Price
$69.01
Total Value
$601.87K
Shares Held After
496,965
% of Holdings
1.7%
Bolt Biotherapeutics, Inc. (BOLT)
Quinn William P. — Director
Shares
6,545
Price
$3.32
Total Value
$21.72K
Shares Held After
34,516
% of Holdings
15.9%
Bolt Biotherapeutics, Inc. (BOLT)
Nemec Sarah — Senior VP, Finance and PAO
Shares
2,922
Price
$3.32
Total Value
$9.70K
Shares Held After
21,159
% of Holdings
12.1%
Bolt Biotherapeutics, Inc. (BOLT)
Yonehiro Grant — Chief Operating Officer
Shares
4,909
Price
$3.32
Total Value
$16.29K
Shares Held After
24,119
% of Holdings
16.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
240
Price
$51.48
Total Value
$12.36K
Shares Held After
25,000
% of Holdings
1.0%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,844
Price
$50.71
Total Value
$93.51K
Shares Held After
25,240
% of Holdings
6.8%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
2,916
Price
$50.03
Total Value
$145.89K
Shares Held After
27,084
% of Holdings
9.7%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
289
Price
$51.49
Total Value
$14.88K
Shares Held After
38,000
% of Holdings
0.8%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
2,194
Price
$50.72
Total Value
$111.27K
Shares Held After
38,289
% of Holdings
5.4%
Enliven Therapeutics, Inc. (ELVN)
Hohl Benjamin — CHIEF FINANCIAL OFFICER
Shares
3,535
Price
$50.03
Total Value
$176.85K
Shares Held After
40,483
% of Holdings
8.0%
Pharvaris N.V. (PHVS)
Lu Peng — President
Shares
100,000
Price
$35.00
Total Value
$3.50M
Shares Held After
64,953
% of Holdings
60.6%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
200,000
Price
$35.00
Total Value
$7.00M
Shares Held After
115,167
% of Holdings
63.5%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
20,000
Price
$38.27
Total Value
$765.47K
Shares Held After
73,969
% of Holdings
21.3%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
14,493
Price
$38.56
Total Value
$558.81K
Shares Held After
10,500
% of Holdings
58.0%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
52,500
Price
$37.89
Total Value
$1.99M
Shares Held After
15,167
% of Holdings
77.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$501.60
Total Value
$80.26K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
468
Price
$500.09
Total Value
$234.04K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
332
Price
$499.10
Total Value
$165.70K
Shares Held After
325,071
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
151
Price
$497.79
Total Value
$75.17K
Shares Held After
325,403
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,953
Price
$497.17
Total Value
$970.98K
Shares Held After
325,554
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,182
Price
$496.21
Total Value
$1.08M
Shares Held After
327,507
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,905
Price
$495.11
Total Value
$943.18K
Shares Held After
329,689
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,750
Price
$494.34
Total Value
$865.10K
Shares Held After
331,594
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
599
Price
$493.22
Total Value
$295.44K
Shares Held After
333,344
% of Holdings
0.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
34,000
Price
$98.60
Total Value
$3.35M
Shares Held After
519,209
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$501.58
Total Value
$160.51K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
125
Price
$500.80
Total Value
$62.60K
Shares Held After
45,492
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,160
Price
$499.75
Total Value
$579.71K
Shares Held After
45,617
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
843
Price
$498.74
Total Value
$420.44K
Shares Held After
46,777
% of Holdings
1.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
700
Price
$104.39
Total Value
$73.07K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,400
Price
$497.54
Total Value
$696.56K
Shares Held After
47,620
% of Holdings
2.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
1,100
Price
$103.20
Total Value
$113.52K
Shares Held After
700
% of Holdings
61.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
2,873
Price
$496.58
Total Value
$1.43M
Shares Held After
49,020
% of Holdings
5.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,501
Price
$102.39
Total Value
$358.47K
Shares Held After
1,800
% of Holdings
66.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,579
Price
$495.97
Total Value
$783.13K
Shares Held After
51,893
% of Holdings
3.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
6,771
Price
$101.37
Total Value
$686.38K
Shares Held After
5,301
% of Holdings
56.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
7,928
Price
$100.43
Total Value
$796.21K
Shares Held After
12,072
% of Holdings
39.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
376
Price
$68.45
Total Value
$25.74K
Shares Held After
1,296,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
9,624
Price
$67.83
Total Value
$652.80K
Shares Held After
1,296,970
% of Holdings
0.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
800
Price
$43.00
Total Value
$34.40K
Shares Held After
13,115
% of Holdings
5.7%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
24,000
Price
$0.21
Total Value
$4.99K
Shares Held After
126,822
% of Holdings
18.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
6,802
Price
$64.95
Total Value
$441.80K
Shares Held After
432,886
% of Holdings
1.5%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
101,691
Price
$64.59
Total Value
$6.57M
Shares Held After
439,688
% of Holdings
18.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
8,282
Price
$65.07
Total Value
$538.92K
Shares Held After
117,066
% of Holdings
6.6%
Caris Life Sciences, Inc. (CAI)
Brille Brian J — Director
Shares
400,000
Price
$30.33
Total Value
$12.13M
Shares Held After
230,303
% of Holdings
63.5%
Showing 1–50 of 108 transactions (page 1 of 3)